CVS said today it’s planning to sell a generic EpiPen competitor at a fraction of the price. Under pressure from lawmakers and the public last year, Mylan announced a generic version of the life-saving auto-injector at a list price of $300. CVS Health says its version will sell for only $110. That’s down significantly from the $600 Mylan had been charging. USA Today has more about the announcement.
collections
NewsletterCourses and LearningAdvertiseCurrent IssueTech Forecast
What’s next for hardware, software, and services
Most Innovative Companies
Our annual guide to the businesses that matter the most
Most Creative People
Leaders who are shaping the future of business in creative ways
World Changing Ideas
New workplaces, new food sources, new medicine--even an entirely new economic system
Innovation By Design
Celebrating the best ideas in business
Follow us:
